AbbVie Inc (ABBV)
171.70
+3.94
(+2.35%)
USD |
NYSE |
Nov 21, 16:00
171.97
+0.27
(+0.16%)
After-Hours: 20:00
AbbVie Market Cap: 303.42B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 296.46B |
| November 19, 2024 | 294.35B |
| November 18, 2024 | 293.84B |
| November 15, 2024 | 291.56B |
| November 14, 2024 | 299.76B |
| November 13, 2024 | 301.03B |
| November 12, 2024 | 302.34B |
| November 11, 2024 | 308.24B |
| November 08, 2024 | 352.54B |
| November 07, 2024 | 354.33B |
| November 06, 2024 | 355.55B |
| November 05, 2024 | 356.40B |
| November 04, 2024 | 354.26B |
| November 01, 2024 | 359.70B |
| October 31, 2024 | 360.27B |
| October 30, 2024 | 356.08B |
| October 29, 2024 | 334.78B |
| October 28, 2024 | 335.19B |
| October 25, 2024 | 331.95B |
| October 24, 2024 | 335.13B |
| October 23, 2024 | 332.00B |
| October 22, 2024 | 333.56B |
| October 21, 2024 | 329.64B |
| October 18, 2024 | 333.74B |
| October 17, 2024 | 333.22B |
| Date | Value |
|---|---|
| October 16, 2024 | 336.56B |
| October 15, 2024 | 339.04B |
| October 14, 2024 | 345.73B |
| October 11, 2024 | 343.15B |
| October 10, 2024 | 343.44B |
| October 09, 2024 | 344.14B |
| October 08, 2024 | 341.07B |
| October 07, 2024 | 342.13B |
| October 04, 2024 | 343.33B |
| October 03, 2024 | 345.38B |
| October 02, 2024 | 347.80B |
| October 01, 2024 | 348.05B |
| September 30, 2024 | 348.97B |
| September 27, 2024 | 344.07B |
| September 26, 2024 | 338.96B |
| September 25, 2024 | 337.83B |
| September 24, 2024 | 341.81B |
| September 23, 2024 | 342.37B |
| September 20, 2024 | 341.73B |
| September 19, 2024 | 342.00B |
| September 18, 2024 | 340.80B |
| September 17, 2024 | 341.70B |
| September 16, 2024 | 345.73B |
| September 13, 2024 | 343.04B |
| September 12, 2024 | 342.71B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
95.25B
Minimum
Mar 23 2020
360.27B
Maximum
Oct 31 2024
233.93B
Average
247.14B
Median
Market Cap Benchmarks
| Amgen Inc | 155.82B |
| Johnson & Johnson | 374.39B |
| Eli Lilly and Co | 711.90B |
| Merck & Co Inc | 252.58B |
| Pfizer Inc | 142.44B |
Market Cap Related Metrics
| PE Ratio | 59.62 |
| PS Ratio | 5.482 |
| Price to Book Value | 50.30 |
| Price to Free Cash Flow | 19.49 |
| Price | 171.70 |
| Earnings Yield | 1.68% |
| Operating PE Ratio | 20.98 |
| Normalized PE Ratio | 54.42 |